Instead of simply funding more grants, we suggest using some of the windfall to provide an opportunity for fresh college graduates to pursue two years of research in the nation’s service while the job market is bottoming out. Call it “Research for America.” Our proposal would put young Americans to work and support science — without setting off a later bust cycle in research support, as previous funding booms have done.

NEWBURY, England, March 20 /PRNewswire/ --

- Unique Online Analytics Software Launched That Captures and Analyses Visitor Interaction With Multimedia Applications Such as Adobe Flash, Flex, Windows Media Player, QuickTime or Real Player

Speed-Trap, the online insight software provider http://www.speed-trap.com/aboutus.aspx launches a unique capability to capture detailed data on website visitors' interaction with Multimedia applications, such as Adobe Flash, Windows Media Player or QuickTime via an extension to their Patented Dynamic Collection(TM) technology - multimedia application web tracking.

COPENHAGEN, March 20 /PRNewswire/ --

- EZN3042 - a Survivin Inhibitor Jointly Developed by Enzon Pharmaceuticals and Santaris Pharma Advances into the Clinic for Patients With Solid Tumors and Lymphomas

Santaris Pharma announced today that the fourth LNA-based drug has been brought into the clinic. In the USA several patients with cancer have now been treated with the Company's Survivin inhibitor, which is jointly developed by Santaris Pharma and Enzon Pharmaceuticals. The U.S. Food and Drug Administration (FDA) recently accepted Enzon Pharma­ceutical's Investigational New Drug (IND) application for the use of the LNA-based Survivin inhibitor.

PHILADELPHIA, Pennsylvania and DUBLIN, Ireland, March 20 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) announces that it has filed a lawsuit in the U.S. District Court of the Southern District of New York against Mylan Inc., Mylan Pharmaceuticals Inc. and Matrix Laboratories Limited (collectively Mylan) for infringement of Shire's patent: U.S. Patent No. 5,968,976 ('976 Patent).

The lawsuit was filed in response to an Abbreviated New Drug Application (ANDA) filed by Mylan seeking FDA approval to market and sell generic versions of Shire's 500 mg, 750 mg, and 1 g FOSRENOL(R) (lanthanum carbonate) products.

ZURICH, Switzerland, March 20 /PRNewswire/ -- A new, innovative study shows that a single dose of palonosetron, the second generation 5-HT3 antagonist, plus dexamethasone not only prevents chemotherapy-induced nausea and vomiting (CINV), but also allows adequate caloric intake in oncology patients. Data presented today at the ESMO Symposium on Cancer and Nutrition in Zurich, Switzerland

SHENZHEN, China, March 20 /PRNewswire/ --

- Credit Facility Allows ZTE to Expand Global Reach and Introduce New Technologies

ZTE Corporation (ZTE) (H share stock code: 0763.HK / A share stock code: 000063.SZ), a leading global provider of telecommunications equipment and network solutions, today announced that it has entered into a strategic partnership with China Development Bank by signing a Development of Financial Cooperation Agreement. This partnership further strengthens the solid relationship the two organizations have previously developed.

MOSCOW, March 20 /PRNewswire/ -- A high-tech Photonics exhibition, which is to be held at Expocentre (Moscow) on April 20 - 23, 2009, will include a special section. It will be completely devoted to laser nanotechnologies, which are considerably transforming the image of modern electronics.

BERLIN and LONDON, March 20 /PRNewswire/ -- The London IFE 2009 international food drink event has over the last few days been introducing trade visitors to the latest trends in the food and beverage sector. Through ngn - new generation gmbh's interactive portal, exhibition organisers Fresh RM (a joint venture between Reed Exhibitions and Montgomery Exhibitions) have also for the first time been offering interested parties worldwide a comprehensive view of the entire exhibitor portfolio online.

LONDON, March 20 /PRNewswire/ --

Axispoint Solutions Ltd., a subsidiary of Axispoint, Inc., a leading provider of technology solutions, today announced the company has acquired the assets of Baseline Consultancy Ltd., a niche technology consulting company located in Crawley, Sussex. The acquisition enables Axispoint Solutions Ltd. to further expand its footprint in the UK, and adds key Microsoft and Cisco expertise that will serve as a valuable addition to the solution offerings in which Axispoint specialises: Business Process Management, Application Development, Virtualisation, and Infrastructure Solutions.